During the past decade, Matsuda Cardiovascular Clinic conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 4 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Matsuda Cardiovascular Clinic" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Canadian VIGOUR Centre" with 1 trials as a collaborator, "Duke Clinical Research Institute" with 1 trials as a collaborator and "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Matsuda Cardiovascular Clinic" are "Atrial Fibrillation" (2 trials), "Chronic Heart Failure With Preserved Ejection Fraction" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "Heart Failure" (1 trials) and "Prevention of Stroke or Systemic Embolism" (1 trials). Many other conditions were trialed in "Matsuda Cardiovascular Clinic" in a lesser frequency.

Most popular intervention types in "Matsuda Cardiovascular Clinic" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials), "Asundexian (BAY2433334)" (1 trials) and "Asundexian matching placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Matsuda Cardiovascular Clinic" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Matsuda Cardiovascular Clinic". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Matsuda Cardiovascular Clinic, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Matsuda Cardiovascular Clinic, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".